Halozyme Therapeutics Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| BLACKROCK, INC. | 05/13/2026 | 13.27 M | $857.32 M | 0.85% | 11.07% |
| 05/15/2026 | 5.27 M | $340.68 M | 100.00% | 4.40% | |
| 05/08/2026 | 5.25 M | $339.26 M | 100.00% | 4.38% | |
| STATE STREET CORP | 05/15/2026 | 4.94 M | $319.13 M | -3.59% | 4.12% |
| INVESCO LTD. | 05/12/2026 | 4.01 M | $259.33 M | 9.99% | 3.35% |
| BANK OF AMERICA CORP /DE/ | 05/18/2026 | 2.91 M | $188.27 M | 6.56% | 2.43% |
| BOSTON PARTNERS | 05/11/2026 | 2.68 M | $173.43 M | 450.99% | 2.24% |
| MORGAN STANLEY | 05/15/2026 | 2.56 M | $165.60 M | -3.61% | 2.14% |
| WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC | 05/08/2026 | 2.53 M | $163.25 M | 37.06% | 2.11% |
| GEODE CAPITAL MANAGEMENT, LLC | 05/15/2026 | 2.51 M | $161.98 M | 2.98% | 2.09% |
| SNYDER CAPITAL MANAGEMENT L P | 05/14/2026 | 2.32 M | $150.14 M | -3.17% | 1.94% |
| DIMENSIONAL FUND ADVISORS LP | 05/07/2026 | 2.08 M | $134.40 M | -1.16% | 1.74% |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | 05/14/2026 | 1.92 M | $123.97 M | -40.48% | 1.60% |
| D. E. SHAW & CO., INC. | 05/15/2026 | 1.87 M | $120.77 M | 13.29% | 1.56% |
| ALLIANCEBERNSTEIN L.P. | 05/15/2026 | 1.74 M | $116.87 M | -5.39% | 1.45% |
| ROYAL LONDON ASSET MANAGEMENT LTD | 05/01/2026 | 1.61 M | $104.09 M | 17.45% | 1.34% |
| JUPITER ASSET MANAGEMENT LTD | 05/12/2026 | 1.61 M | $103.94 M | 2.47% | 1.34% |
| TWO SIGMA INVESTMENTS, LP | 05/15/2026 | 1.58 M | $102.44 M | 120.94% | 1.32% |
| WELLS FARGO & COMPANY/MN | 05/11/2026 | 1.54 M | $99.25 M | 9.26% | 1.28% |
| FIRST TRUST ADVISORS LP | 05/13/2026 | 1.48 M | $95.80 M | 46.51% | 1.24% |
| FULLER & THALER ASSET MANAGEMENT, INC. | 05/14/2026 | 1.47 M | $94.70 M | 6.21% | 1.22% |
| GW&K INVESTMENT MANAGEMENT, LLC | 05/13/2026 | 1.39 M | $90.09 M | 11.10% | 1.16% |
| LSV ASSET MANAGEMENT | 05/11/2026 | 1.37 M | $88.64 M | 5.42% | 1.14% |
| MIZUHO MARKETS AMERICAS LLC | 05/14/2026 | 1.32 M | $85.54 M | 4.33% | 1.10% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 05/15/2026 | 1.29 M | $83.34 M | 3.84% | 1.08% |
| CONGRESS ASSET MANAGEMENT CO /MA | 04/14/2026 | 1.28 M | $82.76 M | -1.66% | 1.07% |
| JANUS HENDERSON GROUP PLC | 05/18/2026 | 1.23 M | $79.74 M | 42.79% | 1.03% |
| STEPHENS INVESTMENT MANAGEMENT GROUP LLC | 04/28/2026 | 1.22 M | $78.76 M | -0.41% | 1.02% |
| MACQUARIE MANAGEMENT HOLDINGS, INC. | 05/15/2026 | 1.19 M | $76.71 M | -21.83% | 0.99% |
| TD ASSET MANAGEMENT INC | 05/11/2026 | 1.17 M | $75.53 M | 25.43% | 0.98% |
| FRANKLIN RESOURCES INC | 05/13/2026 | 1.16 M | $74.78 M | -4.35% | 0.97% |
| EPOCH INVESTMENT PARTNERS, INC. | 05/14/2026 | 1.14 M | $73.57 M | 113.44% | 0.95% |
| FEDERATED HERMES, INC. | 05/11/2026 | 1.12 M | $72.60 M | -28.66% | 0.94% |
| CAISSE DE DEPOT ET PLACEMENT DU QUEBEC | 05/14/2026 | 1.12 M | $72.46 M | -8.40% | 0.94% |
| NORTHERN TRUST CORP | 05/14/2026 | 1.11 M | $71.82 M | 1.36% | 0.93% |
| BANK OF MONTREAL /CAN/ | 05/13/2026 | 1.06 M | $68.22 M | 34.60% | 0.88% |
| AQR CAPITAL MANAGEMENT LLC | 05/15/2026 | 1.02 M | $64.82 M | -12.25% | 0.85% |
| BANK OF NEW YORK MELLON CORP | 05/05/2026 | 983.84 K | $63.59 M | 2.36% | 0.82% |
| UBS GROUP AG | 05/05/2026 | 914.00 K | $59.07 M | -33.07% | 0.76% |
| CAPITAL WORLD INVESTORS | 05/13/2026 | 871.90 K | $56.35 M | -0.91% | 0.73% |
| JANE STREET GROUP, LLC | 05/12/2026 | 831.71 K | $53.75 M | 406.08% | 0.69% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 05/15/2026 | 789.43 K | $51.02 M | -9.98% | 0.66% |
| VANGUARD FIDUCIARY TRUST CO | 05/08/2026 | 747.36 K | $48.30 M | 100.00% | 0.62% |
| GOTHAM ASSET MANAGEMENT, LLC | 05/15/2026 | 746.84 K | $48.27 M | 69.85% | 0.62% |
| RENAISSANCE TECHNOLOGIES LLC | 05/14/2026 | 731.81 K | $47.30 M | 30.05% | 0.61% |
| GOLDMAN SACHS GROUP INC | 05/15/2026 | 730.14 K | $47.19 M | 59.37% | 0.61% |
| LOS ANGELES CAPITAL MANAGEMENT LLC | 05/08/2026 | 689.92 K | $44.59 M | -37.05% | 0.58% |
| BOSTON TRUST WALDEN CORP | 04/24/2026 | 679.56 K | $43.92 M | -13.08% | 0.57% |
| ROYAL BANK OF CANADA | 05/15/2026 | 658.29 K | $42.55 M | 6.62% | 0.55% |
| JPMORGAN CHASE & CO | 05/13/2026 | 633.73 K | $39.37 M | 45.84% | 0.53% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Halozyme Therapeutics Inc. institutional Ownership - FAQ's
During the previous two years, 844 institutional investors and hedge funds held shares of Halozyme Therapeutics Inc.. The most heavily invested institutionals were:
BlackRock, Inc.: 13.27 M
STATE STREET CORP: 4.94 M
Invesco Ltd.: 4.01 M
BANK OF AMERICA CORP /DE/: 2.91 M
Boston Partners: 2.68 M
MORGAN STANLEY: 2.56 M
100.51% of Halozyme Therapeutics Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 175.50 M shares in the last 24 months. This purchase volume represents approximately $11.96 B in transactions.